Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Sapkota, Binaya ^a   Shrestha, Saroj Kumar ^b   Poudel, Sunil ^b  

^a KATHMANDU UNIVERSITY   (Nepal)

^b Civil Service Hospital of Nepal   (Nepal)

Author keywords

Activated partial thromboplastin time; Diabetes mellitus; Fibrinogen

Indexed keywords

ANTIDIABETIC AGENT; FIBRINOGEN;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NEPAL; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTIAL THROMBOPLASTIN TIME; TEACHING HOSPITAL; TERTIARY HEALTH CARE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FIBRINOGEN; HOSPITALS, TEACHING; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NEPAL; PARTIAL THROMBOPLASTIN TIME; TERTIARY HEALTHCARE;

EID: 84888099050     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-485     Document Type: Article

References (16)

1. Management of diabetes and hyperglycemia in hospitals. Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG, Hirsch IB, Diabetes Care 2004 27 553 591 (Pubitemid 38174086)
2. Hyperglycemia: a prothrombotic factor? Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JCM, Hoekstra JBL, J Thromb Haemost 2010 8 1663 1669
3. Diabetes, oxidative stress, and antioxidants: a review. Maritim AC, Sanders RA, Watkins JB, J Biochem Mol Toxicol 2003 17 24 38 (Pubitemid 36410972)
4. Epidemiological association between fasting plasma glucose and shortened APTT. Lippi G, Franchini M, Targher G, Montagnana M, Salvagno GL, Guidi GC, Favaloro EJ, Clin Biochem 2009 42 118 120
5. Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: Correlation with plasma glucagon concentrations. Barazzoni R, Zanetti M, Davanzo G, Kiwanuka E, Carraro P, Tiengo A, Tessari P, J Clin Endocrinol Metab 2000 85 3121 3125
6. A laboratory evaluation into the short activated partial thromboplastin time. Mina A, Favaloro EJ, Mohammed S, Koutts J, Blood Coagul Fibrinolysis 2010 21 152 157
7. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Tripodi A, Chantarangkul V, Martinelli I, Bucciarelli P, Mannucci PM, Blood 2004 104 3631 3634 (Pubitemid 39564438)
8. Diabetes mellitus as a prothrombotic condition. Grant PJ, J Intern Med 2007 262 157 172 (Pubitemid 47090159)
9. Partial thromboplastin time: prediction of adverse events and poor prognosis by low abnormal values. Reddy NM, Hall SW, Mackintosh FR, Arch Intern Med 1999 159 2706 2710
10. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S, Circulation 2003 108 420 425 (Pubitemid 36935534)
11. Reduced fibrinogen survival in diabetes mellitus: a reversible phenomenon. Jones RL, Peterson CM, J Clin Invest 1979 63 485 493 (Pubitemid 9130212)
12. Hyperglycemia-induced thrombin formation in diabetes: the possible role of oxidative stress. Ceriello A, Giacomello R, Stel G, Motz E, Taboga C, Tonutti L, Pirisi M, Falleti E, Bartoli E, Diabetes 1995 44 924 928
13. Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values. Zhao Y, Zhang J, Zhang J, Wu J, PLoS One 2011 6 1 4
14. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Festa A, D'Agostino R, Tracy RP, Haffner SM, Diabetes 2002 51 1131 1137 (Pubitemid 34438360)
15. Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism. Korte W, Clarke S, Lefkowitz JB, Am J Clin Pathol 2000 113 123 127 (Pubitemid 30217347)
16. Shortened activated partial thromboplastin time: causes and management. Lippi G, Salvagno GL, Ippolito L, Franchini M, Favaloro EJ, Blood Coagul Fibrinolysis 2010 21 459 463